Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Ventas Issues Business Update, Raises 2025 Normalized FFO Guidance


Ventas, Inc. VTR recently provided an business update that highlights delivering profitable organic growth in the senior housing. This healthcare REIT also raised its normalized funds from operations (FFO) per share guidance for 2025.

The fundamentals of senior housing continue to be healthy while entering the key selling season, driven by the record growing population aged 80 and above. The key selling season is underway, with projected spot occupancy growth ranging from +30 basis points (bps) to +50 bps sequentially from March 31, 2025, to May 31, 2025.

Ventas’s 2025 Senior Housing Operating Portfolio (SHOP) segment's same-store cash net operating income (NOI) is anticipated to be between 12% to 16%, compared to the prior range of 11% to 16%. It expects SHOP same-store cash NOI year-over-year growth in second half of 2025 to be higher than the first half of 2025, due to timing and slope of key selling season.

The company projected May quarter-to-date same-store average occupancy growth of +230 bps year over year. It also projected May year-to-date same-store average occupancy growth of approximately 270 bps.

2025 Normalized FFO Guidance Raise

Ventas expects 2025 normalized FFO per share in the range of $3.36-$3.46, revised from $3.35-$3.46 stated earlier. The 2025 normalized FFO per share represents approximately 7% year-over-year growth at the midpoint of the guidance range, led by SHOP. The Zacks Consensus Estimate of $3.44 per share stands within the given range.

VTR: In a Snapshot

Ventas’ diverse portfolio of healthcare real estate assets in the key markets of the United States and the U.K. is well-poised to capitalize on the favorable industry fundamentals. The SHOP is likely to benefit from the aging population and the rising healthcare expenditures by senior citizens. The outpatient medical portfolio is expected to gain from the favorable outpatient visit trends. Ventas’ accretive investments to expand its research portfolio also look promising.

Over the past six months, shares of this Zacks Rank #3 (Hold) company have gained 5% against the industry's decline of 5.3%.

 

Zacks Investment Research
Image Source: Zacks Investment Research

 

Stocks to Consider

Some better-ranked stocks from the broader REIT sector are VICI Properties VICI and W.P. Carey WPC, each currently carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Zacks Consensus Estimate for VICI’s 2025 FFO per share has moved one cent northward to $2.34 over the past month.

The consensus estimate for WPC’s 2025 FFO per share has been revised upward by 1% to $4.88 over the past month.

Note: Anything related to earnings presented in this write-up represents FFO, a widely used metric to gauge the performance of REITs.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Ventas, Inc. (VTR): Free Stock Analysis Report
 
W.P. Carey Inc. (WPC): Free Stock Analysis Report
 
VICI Properties Inc. (VICI): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research


Source Zacks-com

Like: 0
Teilen
At Zacks, we are dedicated to independent investment research, helping investors succeed through tools like our Zacks Rank stock-rating system, which has averaged +23.89% annual returns since 1988. Founded on the discovery that earnings estimate revisions drive stock prices, we offer purely mathematical, unbiased ratings, along with additional innovations like the Price Response Indicator, Earnings ESP, and specialized rankings for mutual funds and ETFs.
...
Rechtlicher Hinweis

Kommentare